Package 63868-148-14

{"route": ["ORAL"], "spl_id": "2435d335-106c-2322-e063-6394a90a1b26", "openfda": {"nui": ["N0000193956", "N0000008867", "N0000009560"], "unii": ["495W7451VQ"], "rxcui": ["310621"], "spl_set_id": ["c20f64e3-485b-4ea7-b73d-56e5c898ed2e"], "pharm_class_pe": ["Decreased Respiratory Secretion Viscosity [PE]", "Increased Respiratory Secretions [PE]"], "pharm_class_epc": ["Expectorant [EPC]"], "manufacturer_name": ["CHAIN DRUG MARKETING ASSOCIATION INC"], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": false, "description": "2 BLISTER PACK in 1 CARTON (63868-148-14)  / 7 TABLET, EXTENDED RELEASE in 1 BLISTER PACK", "package_ndc": "63868-148-14", "marketing_end_date": "20270228", "marketing_start_date": "20210917"}], "brand_name": "Maximum Strength Mucus Relief", "product_id": "63868-148_2435d335-106c-2322-e063-6394a90a1b26", "dosage_form": "TABLET, EXTENDED RELEASE", "pharm_class": ["Decreased Respiratory Secretion Viscosity [PE]", "Expectorant [EPC]", "Increased Respiratory Secretions [PE]"], "product_ndc": "63868-148", "generic_name": "Guaifenesin", "labeler_name": "CHAIN DRUG MARKETING ASSOCIATION INC", "product_type": "HUMAN OTC DRUG", "brand_name_base": "Maximum Strength Mucus Relief", "active_ingredients": [{"name": "GUAIFENESIN", "strength": "1200 mg/1"}], "application_number": "ANDA213420", "marketing_category": "ANDA", "marketing_end_date": "20270228", "marketing_start_date": "20210917"}